Remote Blood-Draw Dried-Spot Device Market Growth Expected to Reach $1.72 Billion by 2030 with 13.2% CAGR
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Increase Is Anticipated For The Remote Blood-Draw Dried-Spot Device Market Over The 2026–2030 Period?
The remote blood-draw dried-spot device market size has experienced rapid expansion in recent years. Its value is projected to increase from $0.92 billion in 2025 to $1.05 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 13.5%. This historical expansion can be linked to factors such as increased remote diagnostics, the demand for patient convenience, the broadening of lab testing services, the implementation of newborn screening programs, and the general rise of telemedicine.
The remote blood-draw dried-spot device market size is anticipated to expand rapidly in the coming years. It is projected to reach $1.73 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 13.2%. This expected growth during the forecast period is primarily driven by the expansion of home healthcare, enhanced chronic disease monitoring, the advancement of digital pathology, optimized logistics, and population health management initiatives. Significant trends for this period encompass at-home blood sample collection, the rise of mail-in diagnostic testing, the development of minimally invasive sampling devices, innovations in microfluidic blood collection, and the move towards decentralized diagnostic testing.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=29173&type=smp
What Underlying Factors Are Accelerating The Growth Of The Remote Blood-Draw Dried-Spot Device Market?
The rising focus on personalized medicine is anticipated to fuel the expansion of the remote blood-draw dried-spot device market moving forward. Personalized medicine involves customizing medical care and prevention plans to an individual’s unique genetic, molecular, and clinical traits to achieve the best results. The uptake of personalized medicine is growing, as progress in genomics allows for accurate identification of genetic variations influencing disease risk and treatment effectiveness, thereby facilitating more potent and targeted therapies. Remote blood-draw dried-spot devices assist personalized medicine by providing an easy way to collect small blood samples at home, enabling regular tracking of biomarkers and genetic data to inform customized treatment and therapeutic choices. For example, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, reported that the FDA cleared 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. The personalized treatments given approval in 2023 further comprised seven cancer drugs and three for other illnesses and conditions. Consequently, the heightened focus on personalized medicine is propelling the growth of the remote blood-draw dried-spot device market.
How Is The Remote Blood-Draw Dried-Spot Device Market Segmented Across Key Categories?
The remote blood-draw dried-spot device market covered in this report is segmented –
1) By Product Type: Filter Paper Devices, Microfluidic Devices, Other Product Types
2) By Sample Type: Whole Blood, Plasma, Serum, Other Sample Types
3) By Distribution Channel: Direct Sales, Online Retail, Pharmacies, Other Distribution Channels
4) By Application: Disease Diagnosis, Therapeutic Drug Monitoring, Newborn Screening, Forensic Testing, Other Applications
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings, Other End-Users
Subsegments:
1) By Filter Paper Devices: Whole Blood Collection Cards, Plasma Separation Cards
2) By Microfluidic Devices: Integrated Microchannel Systems, Capillary-Driven Microfluidic Chips
3) By Other Product Types: Volumetric Absorptive Micro sampling Devices, Capillary Blood Collection Tubes
Which Upcoming Trends Are Expected To Influence The Remote Blood-Draw Dried-Spot Device Market?
Companies operating within the remote blood-draw dried-spot device market are concentrating on implementing advanced methods, such as decentralized sampling, to allow for at-home or remote blood collection, thereby improving patient convenience and enhancing the efficiency of clinical trials. Decentralized sampling describes the practice of obtaining biological specimens at locations that are practical for patients, rather than requiring them to visit centralized laboratories or clinics, which broadens access, accelerates collection, and provides more flexible engagement in healthcare or research studies. For example, in March 2025, Tasso Inc., a U.S.-based healthcare technology company, introduced a new generation of technology for dried blood spot (DBS) sample collection, primarily developed for clinical trials and sports anti-doping testing. This technology offers a largely painless, convenient, and accurate method for blood sampling, making it well-suited for clinical trials and sports anti-doping testing. It ensures the delivery of accurate volumetric blood samples through a patient-friendly device, which boosts compliance and facilitates remote collection. By simplifying the sampling procedure, lowering participation barriers, and generating high-quality quantitative data, it accelerates drug development and supports decentralized testing models.
Who Are The Dominant Players Shaping The Remote Blood-Draw Dried-Spot Device Market Landscape?
Major companies operating in the remote blood-draw dried-spot device market are Neoteryx Inc., DBS System SA, Tasso Inc., Capitainer AB, Spot On Sciences Inc., HemaXis S.A., Drawbridge Health Inc., RDA Spot Inc., YourBio Health Inc., Lipomic Healthcare Inc., Trajan Scientific and Medical Pty Ltd., Salimetrics LLC, Eastern Business Forms Inc., PanoHealth Inc., RedDrop Dx Inc., Nanowear Inc., Bioanalytical Systems Inc., Phenomenex Inc., Greiner Bio-One International GmbH, Whatman (Cytiva)
Read the full remote blood-draw dried-spot device market report here:
Which Region Is Projected To Dominate The Remote Blood-Draw Dried-Spot Device Market During The Forecast Period?
North America was the largest region in the remote blood-draw dried-spot device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the remote blood-draw dried-spot device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Remote Blood-Draw Dried-Spot Device Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=29173&type=smp
Browse Through More Reports Similar to the Global Remote Blood-Draw Dried-Spot Device Market 2026, By The Business Research Company
Blood Processing Devices And Consumables Market Report 2026
Blood Collection Processing Management Devices Market Report 2026
Capillary Blood Collection Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
